Spike I followed you on SIRI sold at $2.73
and my ELN is looking sweet
Morgan Stanley 9/8/04---Elan remains our favorite stock in our coverage universe,
and we believe now is still a great time to build positions
in the name as we expect three significant positive events
before year end: (1) US approval for Antegren (for
Multiple Sclerosis) by late November and launch soon
afterwards; (2) resolution of the SEC investigation
without a material impact to the company; and (3) US
approval of Prialt (for severe pain) around year end.
We are very bullish for the prospects for Antegren.
and my ELN is looking sweet
Morgan Stanley 9/8/04---Elan remains our favorite stock in our coverage universe,
and we believe now is still a great time to build positions
in the name as we expect three significant positive events
before year end: (1) US approval for Antegren (for
Multiple Sclerosis) by late November and launch soon
afterwards; (2) resolution of the SEC investigation
without a material impact to the company; and (3) US
approval of Prialt (for severe pain) around year end.
We are very bullish for the prospects for Antegren.
Comment